Graves Disease Latest Advances

Find the Latest Research About Graves Disease

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22700 publications

Early treatment responses in childhood Graves' disease: factors affecting the normalization period of thyroid hormones.

Early treatment responses in childhood Graves' disease: factors affecting the normalization period of thyroid hormones.

Journal: Endocrine research
Published: January 23, 2026

Ophthalmology : what's new in 2025

Ophthalmology : what's new in 2025

Journal: Revue medicale suisse
Published: January 22, 2026

Correction to: "Impact of Minimal Dose Strategy Before Antithyroid Drug Discontinuation on Relapse Risk in Graves' Disease".

Correction to: "Impact of Minimal Dose Strategy Before Antithyroid Drug Discontinuation on Relapse Risk in Graves' Disease".

Journal: The Journal of clinical endocrinology and metabolism
Published: January 22, 2026

Transcriptomic Profiling of Orbital Fat Tissue and Ocular Surface Wash in Active Thyroid Eye Disease Requiring Urgent Orbital Decompression.

Transcriptomic Profiling of Orbital Fat Tissue and Ocular Surface Wash in Active Thyroid Eye Disease Requiring Urgent Orbital Decompression.

Journal: Investigative ophthalmology & visual science
Published: January 14, 2026

Corrigendum to N-glycosylation of CD4+ T cell changes with the development in Graves' disease and is sensitive to methimazole treatment [Biochimica et Biophysica Acta General Subjects 1869 (2025) 130824].

Corrigendum to N-glycosylation of CD4+ T cell changes with the development in Graves' disease and is sensitive to methimazole treatment [Biochimica et Biophysica Acta General Subjects 1869 (2025) 130824].

Journal: Biochimica et biophysica acta. General subjects
Published: January 10, 2026

Short and Long Term Effects of Teprotumumab on Diplopia and Strabismus Associated with Thyroid Eye Disease.

Short and Long Term Effects of Teprotumumab on Diplopia and Strabismus Associated with Thyroid Eye Disease.

Journal: Journal of binocular vision and ocular motility
Published: January 08, 2026

Publisher Correction: Effects of effective antithyroid therapy on adiposity and skeletal muscle in patients with hyperthyroidism across gender and age groups.

Publisher Correction: Effects of effective antithyroid therapy on adiposity and skeletal muscle in patients with hyperthyroidism across gender and age groups.

Journal: European review for medical and pharmacological sciences
Published: January 05, 2026

Efficacy and Safety of Adjunctive Bile Acid Sequestrant Therapy for Thyrotoxicosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Efficacy and Safety of Adjunctive Bile Acid Sequestrant Therapy for Thyrotoxicosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Journal: Thyroid : official journal of the American Thyroid Association
Published: December 30, 2025

Association of IL17A rs4711998 and IL1B rs16944 Polymorphism with Anti-Thyroid Peroxidase Serum Level in Autoimmune Thyroid Diseases: A Case-Control Study in Iranian Population.

Association of IL17A rs4711998 and IL1B rs16944 Polymorphism with Anti-Thyroid Peroxidase Serum Level in Autoimmune Thyroid Diseases: A Case-Control Study in Iranian Population.

Journal: Genetic testing and molecular biomarkers
Published: December 30, 2025

Corticosteroids Versus Teprotumumab for the Treatment of Thyroid Eye Disease. Does Either Mitigate the Need for Additional Treatments?

Corticosteroids Versus Teprotumumab for the Treatment of Thyroid Eye Disease. Does Either Mitigate the Need for Additional Treatments?

Journal: Thyroid : official journal of the American Thyroid Association
Published: December 30, 2025

Thyroid Storm-Induced Respiratory Failure Requiring Venovenous Extracorporeal Membrane Oxygenation.

Thyroid Storm-Induced Respiratory Failure Requiring Venovenous Extracorporeal Membrane Oxygenation.

Journal: The Permanente journal
Published: December 29, 2025

How to discontinue potassium iodide in combined therapy with methimazole for initial treatment of Graves' disease.

How to discontinue potassium iodide in combined therapy with methimazole for initial treatment of Graves' disease.

Journal: Endocrine journal
Published: December 24, 2025
Showing 1-12 of 22,700

Last Updated: 02/24/2026